Plus500 Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Plus500 has a total shareholder equity of $701.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.1B and $404.2M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
Faiz karşılama oranı | n/a |
Nakit | US$1.01b |
Eşitlik | US$701.80m |
Toplam yükümlülükler | US$404.20m |
Toplam varlıklar | US$1.11b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Insufficient Growth At Plus500 Ltd. (LON:PLUS) Hampers Share Price
May 09Insufficient Growth At Plus500 Ltd. (LON:PLUS) Hampers Share Price
Jan 09Is Now The Time To Put Plus500 (LON:PLUS) On Your Watchlist?
May 03Here's Why Plus500 (LON:PLUS) Has Caught The Eye Of Investors
Jan 07Do Plus500's (LON:PLUS) Earnings Warrant Your Attention?
Sep 28If You Like EPS Growth Then Check Out Plus500 (LON:PLUS) Before It's Too Late
Mar 31Should You Take Comfort From Insider Transactions At Plus500 Ltd. (LON:PLUS)?
Mar 10Should You Buy Plus500 Ltd. (LON:PLUS) For Its Upcoming Dividend?
Feb 20Are Institutions Heavily Invested In Plus500 Ltd.'s (LON:PLUS) Shares?
Feb 19Plus500 Ltd.'s (LON:PLUS) 3.6% Dividend Yield Looks Pretty Interesting
Jan 29Plus500 (LON:PLUS) Has Rewarded Shareholders With An Exceptional 482% Total Return On Their Investment
Jan 11Should You Be Adding Plus500 (LON:PLUS) To Your Watchlist Today?
Dec 22Have Insiders Been Buying Plus500 Ltd. (LON:PLUS) Shares This Year?
Dec 04Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: PLUS's short term assets ($1.0B) exceed its short term liabilities ($382.0M).
Uzun Vadeli Yükümlülükler: PLUS's short term assets ($1.0B) exceed its long term liabilities ($22.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: PLUS is debt free.
Borcun Azaltılması: PLUS has not had any debt for past 5 years.
Borç Kapsamı: PLUS has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: PLUS has no debt, therefore coverage of interest payments is not a concern.